scorecardresearch
Monday, September 22, 2025
TopicAntibiotics

Topic: antibiotics

As antibiotics turn ineffective against deadly superbugs, ICMR wants curbs on their sale

In a paper, researchers linked to ICMR’s antimicrobial resistance division & others said that while introduction of new antimicrobials offers hope, resistance may develop rapidly.

Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.

All about nafithromycin, first antibiotic developed in India against deadly, drug-resistant bacteria

Developed by Mumbai-based Wockhardt, it will be available under brand name Miqnaf. Administering it once-a-day for 3 days could be significant in addressing drug-resistant pneumonia.

Drug regulator considers making central nod mandatory for all antibiotics in India, even existing ones

This new proposal, being considered by CDSCO, comes in response to concerns over antimicrobial resistance emerging as a massive public health challenge across the globe, including in India.

More people dying from lack of access to antibiotics. It is leading to rise in drug resistance

By 2050, the total number of deaths associated with drug resistance are expected to reach a staggering 169 million.

Up to 10.4 lakh deaths in India in 2019 due to antibiotic-resistant superbugs, says Lancet report

Findings published Tuesday also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050.

In a 1st, ICMR to build algorithms for antibiotic use in common illnesses to curb misuse

ICMR is working on guidelines on empirical use of antibiotics. Misuse of empirical antibiotics leads to antimicrobial resistance, a major public health challenge in India.

‘Dawn of new era in medicine’ — AI helps scientists develop safe form of antibiotic produced by pigs

AI was used to modify Protegrin-1, an antibiotic found in pigs, to be safe for humans. Development has huge potential for tackling antimicrobial resistance, say microbiologists.

Cheap alternatives, API imports — why Penicillin G production, set to resume after 30 yrs, declined

Production of PenG, used to treat tetanus, strep infections, syphilis, pneumonia & more, was stopped in India in 1990s after cheaper alternatives began surfacing in global market.

Antibiotic prescriptions should mention reason, govt tells doctors amid alarm over drug resistance

In a letter sent earlier this month, Union government has also urged pharmacists to stop selling antibiotics over the counter, without a valid prescription from a doctor.

On Camera

Skin cancer is no more an ‘old person’s disease’

The sun isn’t acting alone—it has an accomplice in pollution. Environmental toxins weaken our skin’s natural barrier.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

60 yrs on, veterans recall lessons from 1965 India-Pakistan war. ‘Equipment alone doesn’t win battles’

A common thread runs through the memories of soldiers of the 1965 war—ingenuity, courage and camaraderie that withstood an apparently technologically superior foe.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.